Table 1 Clinicopathological characteristics
Characteristics | Number of patients (%) | PCGF6 expression | ||
|---|---|---|---|---|
Low (%) | High (%) | p value | ||
No. of patients | 31 | 16 | 15 | Â |
Age | ||||
 ≤ 62 | 17 | 8 (47.06) | 9 (52.94) | 1.000 |
 > 62 | 14 | 7 (50.00) | 7 (50.00) | |
Gender | ||||
 Male | 21 | 10 (47.62) | 11 (52.38) | 0.704 |
 Female | 10 | 6 (60.00) | 4 (40.00) | |
Tumor size (cm) | ||||
 ≤ 3 | 19 | 13 (68.42) | 6 (31.58) | 0.705 |
 > 3 | 12 | 7 (55.56) | 5 (44.44) | |
pT status | ||||
 pT1–pT2 | 17 | 11 (64.71) | 6 (35.29) | 0.290 |
 pT3–pT4 | 14 | 6 (42.86) | 8 (57.14) | |
pN status | ||||
 pN0 | 20 | 12 (60.00) | 8 (40.00) | 0.478 |
 pN1–pN3 | 11 | 5 (45.45) | 6 (54.55) | |
TNM stage | ||||
 I–II | 22 | 6 (27.27) | 16 (72.73) | 0.017 |
 III–IV | 9 | 7 (77.78) | 2 (22.22) | |